Literature DB >> 7442802

Potent carcinogenicity of nitrosodiethanolamine in rats.

W Lijinsky, M D Reuber, W B Manning.   

Abstract

Nitrosodiethanolamine is found in synthetic cutting oils and in many cosmetic preparations and is probably the N-nitroso compound to which human exposure is greatest. It is formed by reaction of the commonly used amines diethanolamine and triethanolamine with nitrosating agents. An assessment of the possible risk in human exposure to nitrosodiethanolamine must be based on sound chronic toxicity data. A previously published chronic test of this compound in rats has shown it to induce liver tumours after very high oral doses, and tumours of the nasal cavity after administration of high repeated doses to Syrian hamsters by subcutaneous injection. To improve our understanding of the carcinogenic potency of nitrosodiethanolamine, we undertook a more extensive study, in which the compound was administered at concentrations ranging from 3,900 to 31,250 parts per million (p.p.m.) in drinking water, to groups of rats for about 6 months. We report here that when the animals were killed, all bore hepatocellular carcinomas, many of which metastasized at the higher doses, indicating that nitrosodiethanolamine is a carcinogen of considerable potency in the rat. However, it is inactive or very weakly active in short-term tests, such as the Salmonella mutagenesis test developed by Ames.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7442802     DOI: 10.1038/288589a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  12 in total

1.  Cancer morbidity in workers exposed to cutting fluids containing nitrites and amines.

Authors:  B Järvholm; B Lavenius; G Sällsten
Journal:  Br J Ind Med       Date:  1986-08

2.  Quantitative analysis of flux along the gluconeogenic, glycolytic and pentose phosphate pathways under reducing conditions in hepatocytes isolated from fed rats.

Authors:  J M Crawford; J J Blum
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

3.  Abnormal sex-steroid milieu in young adults with hepatocellular carcinoma.

Authors:  R A Malt; J J Galdabini; B W Jeppsson
Journal:  World J Surg       Date:  1983-03       Impact factor: 3.352

4.  Increased mutagenicity of N-nitrosodiethanolamine in human lymphocyte cultures after activation by alcohol dehydrogenase.

Authors:  I Henn; G Eisenbrand; H Zankl
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

5.  Alcoholdehydrogenase as an activating enzyme for N-nitrosodiethanolamine (NDELA): in vitro activation of NDELA to a potent mutagen in Salmonella typhimurium.

Authors:  G Eisenbrand; E Denkel; B Pool
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

6.  Studies on the metabolic activation of diethanolnitrosamine in animal-mediated and in vitro assays using Escherichia coli K-12 343/113 as an indicator.

Authors:  S Knasmüller; G Stehlik; G Mohn
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

7.  The effect of mixed-function oxidase and amine oxidase inhibitors on the activation of dialkylnitrosamines and 1,2-dimethylhydrazine to bacterial mutagens in mice.

Authors:  P R Kerklaan; S Bouter; J A Zijlstra; G R Mohn
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

8.  Formation of N-alkylated protoporphyrin IX in the livers of mice after diethylnitrosamine treatment.

Authors:  I N White; A G Smith; P B Farmer
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

9.  Cytogenetic effects of N-nitrosodiethanolamine (NDELA) and NDELA-monoacetate in human lymphocytes.

Authors:  U Dittberner; G Eisenbrand; H Zankl
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

10.  Biological monitoring of workers exposed to N-nitrosodiethanolamine in the metal industry.

Authors:  S Monarca; G Scassellati-Sforzolini; F Donato; G Angeli; B Spiegelhalder; C Fatigoni; R Pasquini
Journal:  Environ Health Perspect       Date:  1996-01       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.